{"id":"W1988367968","doi":"10.1182/blood-2012-02-408773","title":"A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia; London Health Sciences Centre; Jewish General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Neutropenia; Internal medicine; Maintenance therapy; Tolerability; Regimen; Rituximab; Phases of clinical research; Population; CD20; Gastroenterology; Surgery; Lymphoma; Oncology; Clinical trial; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002319348,0.0001173158,0.000346523,0.0001358336,0.00001479362,0.000002903146,0.00008683192,0.00007193446,0.00001581541],"category_scores_gemma":[0.00009912693,0.00009773839,0.00003849101,0.0003890948,0.0000887179,0.0001133872,0.00004575719,0.0001480349,0.000005138799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001745045,"about_ca_system_score_gemma":0.0009865001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007157812,"about_ca_topic_score_gemma":0.000018815,"domain_scores_codex":[0.9985532,0.0000721504,0.0003184425,0.0001931394,0.0005357585,0.0003273334],"domain_scores_gemma":[0.999207,0.00006040446,0.0001616548,0.0003103655,0.0001657004,0.00009492869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01869983,0.2412132,0.5834898,0.0008985196,0.001095811,0.000251023,0.04071902,0.00001652082,0.1073544,0.00004162209,0.002625881,0.003594362],"study_design_scores_gemma":[0.6436188,0.01650538,0.1974216,0.0005866786,0.0004741305,0.00002504647,0.00415552,0.00003996773,0.1368298,0.000003825338,0.00006961555,0.0002696407],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983596,0.0001553854,0.000004725591,0.000005012667,0.00004547143,0.001071277,0.00002550051,0.00001097916,0.0003220671],"genre_scores_gemma":[0.9994683,0.000007115596,0.0001343491,0.00001009344,0.00002065666,0.00003912891,0.00002811361,0.00002333935,0.000268861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.624919,"threshold_uncertainty_score":0.4563231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009608775374167903,"score_gpt":0.2575599199963363,"score_spread":0.2479511446221684,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}